secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001193125-25-169818
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics prices $64.4M common stock offering at $3.20 per share
---------------------------------------------------------------------------

- Offering of 18,750,000 shares of common stock at $3.20; underwriters' over-allotment of 2,812,500 shares exercised in full.
- Net proceeds expected approximately $64.4 million after underwriting discounts and expenses.
- Joint book-running managers: Leerink Partners, Guggenheim Securities, Truist Securities, William Blair.
- Offering expected to close July 31, 2025, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525169818/0001193125-25-169818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525169818/d35960d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-169818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer